|
Dr. Robert Schreiber received his BA degree in Chemistry from the State University of New York at Buffalo in 1968 and his PhD in Biochemistry from that same institution in 1973. In 1985, Dr. Schreiber was recruited to the Department of Pathology, Washington University School of Medicine as Professor of Pathology and Microbiology and, since 1990, he has held the rank of Alumni Endowed Professor of Pathology and Immunology at that institution. He is also an Affiliate of the Ludwig Institute for Cancer Research and an Associate Director of the Scientific Advisory Board to the Cancer Research Institute. Schreiber is a member of the Board of Scientific Advisors of the National Cancer Institute. For more than 25 years, Dr. Schreiber's work has focused on the biochemistry and molecular cell biology of cytokines. Dr. Schreiber's work has led to a generalized appreciation of the profound effect of immunity on developing tumors and has contributed critical conceptual and practical support to the fields of tumor immunology and cancer immunotherapy. Dr. Schreiber has authored more than 200 peer reviewed and invited publications and his work has been well recognized. He has received several honors including the Milstein Award for Outstanding Achievements in Research on Interferon and Cytokines from the International Society of Interferon and Cytokine Research (1996); Induction as a Fellow of the American Association for the Advancement of Science (1996); Bonazinga Award for Excellence in Leukocyte Biology Research from the Society for Leukocyte Biology (1998); and the William B. Coley Award for Distinguished Research in Basic and Tumor Immunology from the Cancer Research Institute (2001). Dr. Schreiber has just has completed service as Chairman of the Transplantation, Tolerance and Tumor Immunology (TTT) NIH Study Section. | 